Cargando…
Current Management Strategies in Breast Cancer by Targeting Key Altered Molecular Players
Breast cancer is the second largest disease affecting women worldwide. It remains the most frequently reported and leading cause of death among women in both developed and developing countries. Tamoxifen and raloxifene are commonly used selective estrogen receptor modulators for treatment of breast...
Autores principales: | Ali, Shazia, Mondal, Neelima, Choudhry, Hani, Rasool, Mahmood, Pushparaj, Peter N., Khan, Mohammad A., Mahfooz, Maryam, Sami, Ghufrana A., Jarullah, Jummanah, Ali, Ashraf, Jamal, Mohammad S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771739/ https://www.ncbi.nlm.nih.gov/pubmed/26973813 http://dx.doi.org/10.3389/fonc.2016.00045 |
Ejemplares similares
-
Molecular mechanisms and mode of tamoxifen resistance in breast cancer
por: Ali, Shazia, et al.
Publicado: (2016) -
A Novel Four-Way Complex Variant Translocation Involving Chromosome 46,XY,t(4;9;19;22)(q25:q34;p13.3;q11.2) in a Chronic Myeloid Leukemia Patient
por: Asif, Muhammad, et al.
Publicado: (2016) -
Effect of iron overload on renal functions and oxidative stress in beta thalassemia patients
por: Rasool, Mahmood, et al.
Publicado: (2016) -
Implications of prognostic variables in the assessment of autoimmunity in hepatitis C patients receiving interferon therapy
por: Arooj, Mahwish, et al.
Publicado: (2016) -
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Jeddah, Kingdom of Saudi Arabia
por: Al-Jaouni, Soad K, et al.
Publicado: (2011)